Oncolytics Biotech (ONCY) Current Deferred Revenue (2018)
Oncolytics Biotech (ONCY) recorded Current Deferred Revenue of $4.89 million in Q3 2025, down 0.9% from $4.93 million a year earlier but up 0.7% from the prior quarter.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Current Deferred Revenue (2018) Analysis & Trends
At the end of FY2024, Oncolytics Biotech reported Current Deferred Revenue of $4.92 million, down 1.5% from FY2023.
- Annual Current Deferred Revenue has declined for three straight years, with a five-year compound annual growth rate of -0.6% (FY2019 to FY2024).
- Across earlier years, Current Deferred Revenue came in at $4.99 million in FY2023 (-3.6%), $5.18 million in FY2022 (-3.6%), $5.37 million in FY2021 (+6.9%) and $5.02 million in FY2020 (-1.0%).
- Quarterly Current Deferred Revenue has ranged from $4.69 million in Q1 2025 to $5.48 million in Q2 2021 over the past five years.
- On a year-over-year basis, Current Deferred Revenue has declined for six consecutive quarters, with an average decline of 1.8% over the last eight quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 3.4% in Q4 2021, against a decline of 7.1% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.86 million (Q2 2025), $4.69 million (Q1 2025) and $4.82 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - |
API Access
Oncolytics Biotech Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();